Medicines / Pfizer / Lorbriqua
LorbriquaLorlatinib
Lorbriqua is marketed by Pfizer. 2 packs on NPPA's price list for July 2026, containing Lorlatinib.
- Packs listed
- 2
- Lowest MRP
- ₹102,000
- Per unit
- ₹3,400 to ₹4,875
- Price-controlled packs
- 0 of 2
- Dosage forms
- 1
Packs and prices
- ₹102,000Lorbriqua 25 mg Tablet 30Lorlatinib Tablet 25 mg · ₹3,400 per tablet
- ₹146,250Lorbriqua 100 mg Tablet 30Lorlatinib Tablet 100 mg · ₹4,875 per tablet
The company
Pfizer has 225 packs on the price list, and CDSCO has named it as the manufacturer of 1 failed batch since Aug 2026. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.